Oncothyreon (ONTY) Closes 13.5M Common Offering at $4/Share

Oncothyreon Inc. (Nasdaq: ONTY) has closed the previously announced underwritten public offering of 13,512,500 shares of its common stock at a price to the public of $4.00 per share for gross proceeds of approximately $54.1 million. The shares include 1,762,500 shares of common stock sold pursuant to the over-allotment option granted by the Company to the underwriters, which option was exercised in full. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Oncothyreon, will be approximately $50.3 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Entera Bio Ltd. (ENTX) files for 134.8M share offering by selling stockholders
• MAIA Biotechnology (MAIA) files $150M mixed shelf